pharma · Asthma · Multiple Sclerosis · TEVA
Teva Pharma
Teva Pharma GmbH
Teva Pharma clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
- Employees
- 126
- Programs
- 7
- Drugs
- 407
- Patents
- 185
Teva Pharma projects
7 ClinicalTrials.gov programs sponsored by Teva Pharma.
Teva Pharma has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
TV-44749
Teva Pharma GmbH
Schizophrenia
3 trials -
Fremanezumab
Teva Pharma GmbH
Fibromyalgia
1 trial -
Oral CEP-701
Teva Pharma GmbH
Myeloma
1 trial -
Talampanel
Teva Pharma GmbH
ALS
1 trial -
armodafinil
Teva Pharma GmbH
Schizophrenia
2 trials -
TEV-53408
Teva Pharma GmbH
Vitiligo
1 trial -
TL011
Teva Pharma GmbH
DLBCL
1 trial
Frequently asked questions
How many clinical projects does Teva Pharma have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.